Detalhe da pesquisa
1.
CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.
Am J Hematol
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586986
2.
CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network.
Blood
; 139(5): 792-796, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871363
3.
CAR T-cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes.
Haematologica
; 108(12): 3485-3490, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345469
4.
Layer-by-layer bioassembly of cellularized polylactic acid porous membranes for bone tissue engineering.
J Mater Sci Mater Med
; 28(5): 78, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28386854
5.
Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event.
BMC Cancer
; 16: 384, 2016 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27378078
6.
Liquid chromatography with tandem mass spectrometry for the simultaneous identification and quantification of cardiovascular drugs applied to the detection of substandard and falsified drugs.
J Sep Sci
; 38(4): 562-70, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25521603
7.
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM).
Cancers (Basel)
; 15(16)2023 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627056